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The rapidly increasing use of hormones
in, for example, treatment of menstrual
disorders and menopausal syndrome, testing
for and maintenance of pregnancy and as
oral contraceptives renders the question of
any possible carcinogenic risk of vital
importance. The appearance ofthis authori-
tative publication is therefore timely. It is
one of a series summarizing available evidence
for the carcinogenicity ofindividual chemicals
from information compiled, reviewed and
evaluated by an international panel of
experts in the field, meeting at Lyon in
February, 1974. Although entitled Sex
Hormones" this volume deals only with
steroid derivatives and the synthetic diethyl-
stilboestrol.
After a short introduction on the back-
ground, purpose and mechanism of produc-
tion of the monographs and on evaluation of
data, there follows a general section dealing
in admirable outline with the multifarious
biological activities of the hormones in
relation to growth, differentiation, develop-
ment and function and with their role in
tumour induction. This section also includes
a summary of analytical methods and a very
adequate selection of references. It would
make an excellent introductory textbook
in endocrinology for student use and the book
is well -worth the modest expenditure for this
part alone.
The individual monographs which follow
are grouped into three classes: oestrogens,
progestins and androgens. Rather surpris-
ingly the last group has only one entrant-
testosterone. The format used is clear:
chemical and physical data (including for-
mulae) followed by sections on occurrence
and use and on the biological data, with a
final evaluation by the Working Group and a
list of references.
The authors state very clearly the impos-
sibility at present ofinterpreting animal data
in terms of human hazard but emphasize the
value of animal experiments in providing
clues as to where human risk may arise.
Granted that there is no substitute for direct
observation on the human being, case reports
or epidemiological studies on the effects of
individual hormones are naturally seldom
available. Observations in man which could
not be attributed to the effect of a single
hormone are, howrever, considered together
in a separate section followring the individual
monographs.
The book ends wvith a short statement of
general conclusions in which the panel point
out there is no evidence at present to suggest
that steroid hormones are ultimate carcino-
gens but rather that they act by modification
of pituitary hormone secretion in wlich
prolactin is a factor. From available human
data, the group rather guardedly concludes
that oral contraceptives have not as yet been
shown to affect the risk of breast cancer
although they remain uncommitted with
respect to evidence relating to cervical cancer.
There is no evidence that administration of
steroidal oestrogens for treatment of meno-
pausal syndrome is associated with cancer
risk but diethylstilboestol administered during
pregnancy would appear to expose female
off-spring to risk of vaginal or cervical
adenocarcinoma and probably increases the
risk of endometrial carcinoma in women
with gonadal dysgenesis.
The panel have performed a much needed
and Herculean task in collating and critically
assessing all the relevant information linking
hormones and carcinogenesis. Any omissions
would appear to be due to lack of sound,
published information rather than inadequate
coverage, and it is noted that revised mono-
graphs w-ill be published as new data become
available.
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